Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

University of Rochester in New York

May 2011
A technology that has helped improve eyesight is now more widely available, thanks to approval by the FDA. Created by physicians and scientists at the University of Rochester in New York, the Rochester Nomogram marks an advance for patients who undergo lasik surgery. A company that has licensed the technology from the university announced that the FDA has approved its use in its refractive surgery system. Technolas Perfect Vision GmbH of Munich, Germany, is a cataract and refractive laser company that was formed through a joint venture of Bausch + Lomb and 20/10 Perfect Vision AG. It offers the Nomogram technology in its refractive surgery correction system. The Nomogram adjusts the way a laser interacts with a person’s vision, reducing the chances that the eyes will be near- or farsighted after the procedure. Patients at the Flaum Eye Institute in Rochester have benefited from the research.

AmericasBiophotonicsBusinessEuropeFDAFlaum Eye InstituteGermanyLASIKLasik surgeryNew YorkopticsRapidScanrefractive laserrefractive surgeryRochester NomogramTechnolas Perfect VisionUniversity of RochesterUS Food and Drug Administrationlasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.